GlassScriptPhysician profile
Michael G Eyer
NPI 1033368337
$1,082.02
in general payments reported to CMS, 2019-2025
16 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.87 · 2023: $114 · 2024: $466 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $237.54 | 2023-2025 | |
| Novo Nordisk INC | $144.62 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Exact Sciences Corporation | $140.66 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $107.94 | 2024-2025 | Zepbound, Mounjaro, Kisunla |
| Axsome Therapeutics, INC. | $101.73 | 2025 | Auvelity |
| Merck Sharp & Dohme LLC | $55.45 | 2024 | Gardasil 9, Gardasil, Vaxelis |
| Amgen INC. | $49.94 | 2024-2025 | Otezla, Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $39.49 | 2024-2025 | Breztri, Farxiga |
| Tris Pharma INC | $39.15 | 2024-2025 | Dyanavel Xr |
| Insightec,INC | $29.63 | 2025 | Exablate |
| Teva Pharmaceuticals USA, INC. | $29.04 | 2025 | Austedo Xr |
| Boston Scientific Corporation | $27.87 | 2021 | |
| Ironshore Pharmaceuticals INC. | $26.50 | 2024 | |
| Astellas Pharma US INC | $20.60 | 2024 | Veozah |
| Collegium Pharmaceutical, INC. | $17.83 | 2025 | Jornay Pm |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $14.03 | 2024 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Eyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.